<ѻý>New IDH1 Inhibitor Wins FDA Approval for Acute Myeloid Leukemiaѻý> Olutasidenib led to a 35% response rate in a study of adults with previously treated AML Dec 02, 2022
<ѻý>FDA Greenlights First Fecal Microbiota Productѻý> Rebyota approved for preventing recurrence of C. difficile infection Dec 01, 2022
<ѻý>Watch for Severe Hypocalcemia in Dialysis Patients on Prolia, FDA Warnsѻý> Agency said potential risk may require more frequent blood calcium monitoring Nov 22, 2022
<ѻý>FDA Approves First Drug to Delay Onset of Type 1 Diabetesѻý> Teplizumab will not be subject to a risk evaluation and mitigation strategy program, after all Nov 18, 2022
<ѻý>FDA Panel Endorses Kidney Disease Drug for Serum Phosphorus Controlѻý> Advisors see need for alternatives, citing suboptimal efficacy and tolerance of approved options Nov 17, 2022
<ѻý>After Rejection, Tenapanor for Kidney Disease Faces FDA's Outside Expertsѻý> Drug's effect on serum phosphorus "small and of unclear clinical significance," say FDA reviewers Nov 15, 2022
<ѻý>FDA OKs First Antibody-Drug Conjugate for Platinum-Resistant Ovarian Cancerѻý> Mirvetuximab soravtansine produced responses in almost a third of patients in pivotal trial Nov 15, 2022
<ѻý>Another Adalimumab Biosimilar Seems Set for Interchangeabilityѻý> Trial data pave way for FDA approval Nov 14, 2022
<ѻý>FDA Authorizes IL-1 Drug for Hospitalized COVID Patientsѻý> Anakinra indicated for patients with pneumonia who are at risk of severe respiratory failure Nov 09, 2022
<ѻý>COVID Spread Through Floors, Walls; Infant Pillow Warning; Paul Pelosi Dischargedѻý> Health news and commentary from around the Web gathered by ѻý staff Nov 04, 2022
<ѻý>Pulse Oximeters Need to Work Better for Dark-Skinned Patients, FDA Panel Saysѻý> Warnings to patients and providers, improved accuracy needed, advisors say Nov 02, 2022
<ѻý>The Updated COVID Boosters Could Have Been Betterѻý> From design to implementation, our bivalent shots missed the mark Oct 26, 2022
<ѻý>FDA Broadens Options for Relapsed/Refractory Multiple Myeloma With Teclistamabѻý> Bispecific antibody achieved durable responses in a majority of heavily pretreated patients Oct 25, 2022
<ѻý>Makena Is Just the Latest in Accelerated Approval Mayhemѻý> Congress must take action to reform the process Oct 24, 2022
<ѻý>FDA Approves New CTLA-4 Inhibitor for Cancer Treatmentѻý> Tremelimumab (Imjudo), in combination with durvalumab, lands approval in advanced liver cancer Oct 24, 2022
<ѻý>Thumbs Down for Genetic Test for Opioid Use Disorder, FDA Advisors Sayѻý> False positives, false negatives remain a concern Oct 21, 2022
<ѻý>Revoke Approval of Preterm Birth Drug, FDA Advisors Sayѻý> Makena is ineffective, argued FDA panel Oct 19, 2022
<ѻý>FDA Moves to Pull Controversial Preterm Birth Drug From the Marketѻý> Briefing data show Makena was ineffective in reducing preterm birth, improving neonatal outcomes Oct 14, 2022
<ѻý>Why I Voted 'No' on the New ALS Drugѻý> Here are the shortcomings I saw in the phase II Relyvrio study Oct 13, 2022
<ѻý>FDA Approves At-Home Furosemide for Heart Failureѻý> Strong diuretic to become available outside the hospital setting Oct 10, 2022
<ѻý>FDA OKs Tdap Vaccine for Whooping Cough Protection Before Birthѻý> Boostrix vaccine is to be delivered to the unborn child in the third trimester of pregnancy Oct 07, 2022
<ѻý>The Search Is On for Another Xeno Heart Transplant Recipientѻý> Transplant surgeons discuss testing the concept in more humans Oct 04, 2022
<ѻý>FDA's Power Morcellator Warning Tied to Drop in Distant Leiomyosarcomasѻý> Local and regional illness remained unchanged Oct 04, 2022
<ѻý>Dupilumab Gets First FDA-Approved Indication for Prurigo Nodularisѻý> Significant improvement in itch and nodules at 24 weeks seen in two randomized trials Sep 29, 2022
<ѻý>Gene Therapy for Degenerative Brain Disorder Wins FDA Nodѻý> $3 million price tag for one-time treatment Sep 19, 2022
<ѻý>FDA Finally OKs First Drug for Hepatorenal Syndromeѻý> Pivotal trial data showed terlipressin nearly doubled reversal of the condition Sep 15, 2022
<ѻý>First TYK2 Inhibitor for Psoriasis Wins FDA Approvalѻý> Deucravacitinib significantly outperformed apremilast in two randomized trials Sep 11, 2022
<ѻý>First Approved Treatment for Generalized Pustular Psoriasisѻý> Spesolimab led to complete clearance of pustules within a week in more than half of patients Sep 07, 2022
<ѻý>FDA Data Link Diabetes Drug Class to Gallbladder Diseaseѻý> FAERS analysis turns up dozens of cases of acute cholecystitis tied to GLP-1 receptor agonists Aug 30, 2022
<ѻý>FDA Warns on Potential for Monkeypox Spread via Fecal Transplantѻý> Agency urges additional protections around donor screening Aug 24, 2022
<ѻý>Biden Administration Authorizes Intradermal Use of Monkeypox Vaccineѻý> Move is expected to increase available doses by five-fold Aug 10, 2022
<ѻý>False Claims About COVID Vax Animal Testing Resurfaceѻý> Misinformation promoted by Texas lawmaker in 2021 pops up again on Twitter Aug 09, 2022
<ѻý>I Got Monkeypox Drugs -- Not Everyone Is So Luckyѻý> Increasing access to testing, vaccination, and treatment is critical to slowing the spread Aug 03, 2022
<ѻý>FDA OKs First Interchangeable Ranibizumab Biosimilarѻý> When available, Cimerli qualifies for pharmacy-level substitution for reference drug Aug 03, 2022
<ѻý>Are Skin Lesion Analyzers Ready for Prime Time?ѻý> FDA panel not fully on board to reclassify computer-aided melanoma detection devices Jul 30, 2022
<ѻý>Dear Insurers: It's Time to Cover Weight Loss Drugsѻý> Universal coverage can increase medication access and improve population health Jul 27, 2022
<ѻý>Banned Supplements Still Available to Buy Online After FDA Warningsѻý> FDA should follow up on warning letters, researchers urge Jul 26, 2022
<ѻý>Topical JAK Inhibitor OK'd for Repigmentation of Vitiligoѻý> Significantly more patients achieved 75%, 90% improvement Jul 19, 2022
<ѻý>FDA Getting Tougher on Birth Tissue Companiesѻý> Agency calls out manufacturer on orthopedic indications Jul 06, 2022
<ѻý>FDA Warns of Increased Mortality Risk With Duvelisibѻý> Drug approved for adults with CLL/SLL Jul 01, 2022